메뉴 건너뛰기




Volumn 164, Issue 6, 2011, Pages 1402-1403

A novel approach to the management of inflammatory bacille Calmette-Guérin reactions using topical steroids

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BETAMETHASONE; BETAMETHASONE PLUS FUSIDIC ACID; FUSIDIC ACID; MOMETASONE FUROATE; UNCLASSIFIED DRUG;

EID: 79957591564     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10266.x     Document Type: Letter
Times cited : (2)

References (10)
  • 1
    • 1442333446 scopus 로고    scopus 로고
    • BCG vaccine. WHO position paper
    • World Health Organization.
    • World Health Organization. BCG vaccine. WHO position paper. Wkly Epidemiol Rec 2004; 79: 27-38.
    • (2004) Wkly Epidemiol Rec , vol.79 , pp. 27-38
  • 2
    • 15044348833 scopus 로고    scopus 로고
    • Skin complications of Bacillus Calmette-Guérin immunization
    • Bellet JS, Prose NS,. Skin complications of bacillus Calmette- Guérin immunization. Curr Opin Infect Dis 2005; 18: 97-100. (Pubitemid 40380205)
    • (2005) Current Opinion in Infectious Diseases , vol.18 , Issue.2 , pp. 97-100
    • Bellet, J.S.1    Prose, N.S.2
  • 3
    • 0021156903 scopus 로고
    • BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics
    • Lotte A, Wasz-Höckert O, Poisson N, et al. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 1984; 21: 107-93.
    • (1984) Adv Tuberc Res , vol.21 , pp. 107-193
    • Lotte, A.1    Wasz-Höckert, O.2    Poisson, N.3
  • 5
    • 70449521375 scopus 로고    scopus 로고
    • Local and regional adverse reactions to BCG-SSI vaccination: A 12-month cohort follow-up study
    • Dommergues MA, de la Rocque F, Guy C, et al. Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study. Vaccine 2009; 27: 6967-73.
    • (2009) Vaccine , vol.27 , pp. 6967-6973
    • Dommergues, M.A.1    De La Rocque, F.2    Guy, C.3
  • 6
    • 16544393058 scopus 로고    scopus 로고
    • Percutaneous or intradermal BCG vaccine?
    • Bricks LF,. [Percutaneous or intradermal BCG vaccine?]. J Pediatr (Rio J) 2004; 80: 93-8.
    • (2004) J Pediatr (Rio J) , vol.80 , pp. 93-98
    • Bricks, L.F.1
  • 7
    • 0036164191 scopus 로고    scopus 로고
    • Intradermal BCG vaccination - Adverse reactions and their management
    • Nicol M, Eley B, Kibel M, et al. Intradermal BCG vaccination-adverse reactions and their management. S Afr Med J 2002; 92: 39-42. (Pubitemid 34126674)
    • (2002) South African Medical Journal , vol.92 , Issue.1 , pp. 39-42
    • Nicol, M.1    Eley, B.2    Kibel, M.3    Hussey, G.4
  • 9
    • 2442670977 scopus 로고
    • Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination
    • Hanley SP, Gumb J, Macfarlane JT,. Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination. Br Med J (Clin Res Ed) 1985; 290: 970. (Pubitemid 15110863)
    • (1985) British Medical Journal , vol.290 , Issue.6473 , pp. 970
    • Hanley, S.P.1    Gumb, J.2    Macfarlane, J.T.3
  • 10
    • 3242680613 scopus 로고    scopus 로고
    • Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications
    • Torres-Rojas J, Rondõn-Lugo A, Rosa V,. Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications. Dermatol Online J 2002; 8: 6.
    • (2002) Dermatol Online J , vol.8 , pp. 6
    • Torres-Rojas, J.1    Rondõn-Lugo, A.2    Rosa, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.